目的探讨弥漫大B细胞淋巴瘤(diffuse large B-cell lymphoma,DLBCL)中活化的B细胞相关蛋白MUM1的表达与临床病理特征之间的关系。方法利用组织微阵列免疫组化检测60例DLBCL石蜡包埋组织中MUM1、bcl-6和CD10的表达。结果60例DLBCL被分为...目的探讨弥漫大B细胞淋巴瘤(diffuse large B-cell lymphoma,DLBCL)中活化的B细胞相关蛋白MUM1的表达与临床病理特征之间的关系。方法利用组织微阵列免疫组化检测60例DLBCL石蜡包埋组织中MUM1、bcl-6和CD10的表达。结果60例DLBCL被分为两种抗原表达表型:一种为活化的B细胞表型(A型)表达MUM1;另一种为生发中心B细胞表型(B型),表达CD10和(或)bcl-6但不表达MUM1。60例DLBCL中61.67%为A型,31.67%为B型,其中59.25%中心母细胞型,3/4免疫母细胞型,2/2间变性大B细胞型均为A型。A型在结外和结内DLBCL中分别占61.76%和61.54%,而在胃肠道DLBCL中的比例(47%)显著低于在其他结外DLBCL中的比例(80%,P=0.079)。在MUM-1(+)/bcl-6(+)/CD10(+/-)的病例中,75.00%(12/16)为结外DLBCL,高于在MUM-1(+)/bcl-6(-)/CD10(-)病例中的比例43.75%(7/16),但差异没有显著性(P=0.149)。结论A型(表达MUM1)在DLBCL中的比例较高,提示MUM1表达很可能与DLBCL组织学变异有关,联合检测CD10和bcl-6,可协助DLBCL分型诊断。展开更多
Background：Non-Hodgkin lymphoma is the fourth most common malignant tumors in children,Burkitt lymphoma （BL） accounts for 30-50％ of all pediatric lymphomas.The aim of this study was to investigate the clinicopatho...Background：Non-Hodgkin lymphoma is the fourth most common malignant tumors in children,Burkitt lymphoma （BL） accounts for 30-50％ of all pediatric lymphomas.The aim of this study was to investigate the clinicopathologic features,immunophenotype,Epstein-Barr virus （EBV） infection and c-myc gene rearrangement of sporadic BL in children.Methods：Ninety-two cases of pediatric BL were retrospectively analyzed for clinical features,immunohistochemistry,EBV-encoded RNA （EBER） status by in situ hybridization and c-myc gene rearrangement by fluorescence in situ hybridization.Results：In the 92 cases,male is predominant in sex distribution （M：F =3.38：1）.The average age at diagnosis was 4.97 years.Polypoid BL showed a lower clinical stage （P =0.002）,and advanced clinical stage and low serum albumin level at diagnosis were associated with poor outcome （P =0.024 and 0.053,respectively）.The positive expression of CD10,B-cell lymphoma-6,MUM1 and EBER were 95.7％ （88 cases）,92.4％ （85 cases）,22.8％ （21 cases）,41.3％ （38 cases）,respectively.The expression of MUM1 were not associated with EBV infection status （P =1.000）.c-myc gene rearrangement was detected in 94.6％ （87/92）.Clinical treatment information for 54 cases was collected,21 patients died of tumor after surgery alone,33 patients received surgery and chemotherapy,and of which six patients died shortly afterwords （MUM 1 positive expression in 3 cases,P =0.076）.Conclusions：The anatomical location,growth pattern and serum albumin level of BL were associated with biological behavior.MUM1 may be a potential adverse prognostic marker,and not associated with EBV infection status.展开更多
文摘目的探讨弥漫大B细胞淋巴瘤(diffuse large B-cell lymphoma,DLBCL)中活化的B细胞相关蛋白MUM1的表达与临床病理特征之间的关系。方法利用组织微阵列免疫组化检测60例DLBCL石蜡包埋组织中MUM1、bcl-6和CD10的表达。结果60例DLBCL被分为两种抗原表达表型:一种为活化的B细胞表型(A型)表达MUM1;另一种为生发中心B细胞表型(B型),表达CD10和(或)bcl-6但不表达MUM1。60例DLBCL中61.67%为A型,31.67%为B型,其中59.25%中心母细胞型,3/4免疫母细胞型,2/2间变性大B细胞型均为A型。A型在结外和结内DLBCL中分别占61.76%和61.54%,而在胃肠道DLBCL中的比例(47%)显著低于在其他结外DLBCL中的比例(80%,P=0.079)。在MUM-1(+)/bcl-6(+)/CD10(+/-)的病例中,75.00%(12/16)为结外DLBCL,高于在MUM-1(+)/bcl-6(-)/CD10(-)病例中的比例43.75%(7/16),但差异没有显著性(P=0.149)。结论A型(表达MUM1)在DLBCL中的比例较高,提示MUM1表达很可能与DLBCL组织学变异有关,联合检测CD10和bcl-6,可协助DLBCL分型诊断。
文摘Background：Non-Hodgkin lymphoma is the fourth most common malignant tumors in children,Burkitt lymphoma （BL） accounts for 30-50％ of all pediatric lymphomas.The aim of this study was to investigate the clinicopathologic features,immunophenotype,Epstein-Barr virus （EBV） infection and c-myc gene rearrangement of sporadic BL in children.Methods：Ninety-two cases of pediatric BL were retrospectively analyzed for clinical features,immunohistochemistry,EBV-encoded RNA （EBER） status by in situ hybridization and c-myc gene rearrangement by fluorescence in situ hybridization.Results：In the 92 cases,male is predominant in sex distribution （M：F =3.38：1）.The average age at diagnosis was 4.97 years.Polypoid BL showed a lower clinical stage （P =0.002）,and advanced clinical stage and low serum albumin level at diagnosis were associated with poor outcome （P =0.024 and 0.053,respectively）.The positive expression of CD10,B-cell lymphoma-6,MUM1 and EBER were 95.7％ （88 cases）,92.4％ （85 cases）,22.8％ （21 cases）,41.3％ （38 cases）,respectively.The expression of MUM1 were not associated with EBV infection status （P =1.000）.c-myc gene rearrangement was detected in 94.6％ （87/92）.Clinical treatment information for 54 cases was collected,21 patients died of tumor after surgery alone,33 patients received surgery and chemotherapy,and of which six patients died shortly afterwords （MUM 1 positive expression in 3 cases,P =0.076）.Conclusions：The anatomical location,growth pattern and serum albumin level of BL were associated with biological behavior.MUM1 may be a potential adverse prognostic marker,and not associated with EBV infection status.
